NEW YORK (GenomeWeb News) – Global Genomics Group and Caprion Proteomics said today that they have entered into a collaboration to investigate potential biomarkers and pharmaceutical targets for cardiovascular disease.

Under the agreement, Caprion will identify blood-based protein markers for the ongoing GLOBAL (Genetic Loci and Burden of Atherosclerotic Lesions) study, a multi-center pan-omic study that aims to recruit up to 10,000 patients to characterize disease pathways and biomarkers linked to coronary artery disease.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.